Hemmo Pharma
approved by US FDA & EU
Our Navi Mumbai facility was awarded a GMP compliance certificate from the German Authorities after an inspection of the Hamburg branch back in 2010.

In march 2011, Hemmo Pharmaceuticals received a Preapproval Inspection from the USFDA for desmopressin and Oxytocin and received the letter classifying the facility as acceptable in June 2011.

The facility manufactures under GMP compliance a range of generic as well as proprietary peptides for the indian as well as foreing markets and continues to be one of the key players in the manufacturing of oxytocin worldwide.
Home   |   Privacy Policy   |   Contact Us Website Development by Sharptech Digital Marketing Company
© Hemmo Pharmaceuticals Pvt Ltd.